✦ LIBER ✦

Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease

✍ Scribed by Gehrman, Philip R.; Connor, Donald J.; Martin, Jennifer L.; Shochat, Tamar; Corey-Bloom, Jody; Ancoli-Israel, Sonia

Book ID: 123013293
Publisher: American Psychiatric Publishing Inc
Year: 2009
Tongue: English
Weight: 84 KB
Volume: 17
Category: Article
ISSN: 1064-7481
DOI: 10.1097/JGP.0b013e318187de18

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients With Alzheimer's, Vascular, or Mixed Dementia

✍ RAPPAPORT, S; MARCUS, R; MANOS, G; MCQUADE, R; OREN, D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 388 KB

A 6-month, randomized, double-blind, pla

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

✍ D.P. Devanand; Gregory H. Pelton; Karine Cunqueiro; Harold A. Sackeim; Karen Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Abstract ## Objective In patients with Alzheimer's disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. ## Methods In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of ha

Atomoxetine Augmentation of Cholinestera

Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer Disease: 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Trial Study

✍ Mohs, Richard C.; Shiovitz, Thomas M.; Tariot, Pierre N.; Porsteinsson, Anton P. 📂 Article 📅 2009 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 168 KB

Randomized double-blind placebo-controll

Randomized double-blind placebo-controlled dose-finding trial of intravenous immunoglobulin (octagam® 10%, octapharma AG) in patients with Alzheimer's disease

✍ Farlow, Martin R.; Jessen, Frank; Wietek, Stefan; Melsen, Tina; Haag, Stefan; Do 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P1-387 Results of a randomized, double-b

P1-387 Results of a randomized, double-blind, placebo-controlled trial with the neurotrophic compound cerebroylsin in Alzheimer's disease patients

✍ Antón Álvarez; Marta Laredo; Carolina Sampedro; Ramón Cacabelos; Verónica Coucei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Melissa officinalis extract in the treat

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

✍ Akhondzadeh, S 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 224 KB